Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Ovid Therapeutics Inc. (OVID) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Ovid Therapeutics Inc. (OVID), most recent 12 months reported: revenue $1.58M, net loss $34.49M, free cash flow -$38.33M. Latest balance sheet on file: liquid cash $117.22M. From SEC filings. Others in Pharmaceutical Preparations: Dianthus Therapeutics, Inc. /DE/ · ORAMED PHARMACEUTICALS INC. · Seres Therapeutics, Inc. · CANNAPHARMARX, INC. · LIPOCINE INC. · Cartesian Therapeutics, Inc. · AVENUE THERAPEUTICS, INC. · Dare Bioscience, Inc.

Stock screener

Watchlist